Kryptos Biotechnologies
About:
Kryptos Biotechnologies provides innovative life science systems that reveal the complexity of biology for clinicians and scientists.
Website: https://kryptosbio.com/
Top Investors: Osang Healthcare, SkyDeck Berkeley, FuturePlay, LG Chem, KDB Capital
Description:
Kryptos Biotechnologies provides innovative life science systems that reveal the complexity of biology for clinicians and scientists. The company was founded in 2017 by Jinyong Lee and Jun Ho Son and is based in Hayward, California.
Total Funding Amount:
$21.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Hayward, California, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)kryptosbio.com
Founders:
Jinyong Lee, Jun Ho Son
Number of Employees:
11-50
Last Funding Date:
2024-03-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai